Submit Deal

BIOCON BIOLOGICS LTD

HQ - Bengaluru

Summary

Biocon Biologics operates as a biopharmaceutical company. The Company offers treatment for chronic diseases such as diabetes, oncology, cancer, and autoimmune diseases. Biocon Biologics India serves customers worldwide.

Deals Overview

Total Deals7

Valued Deals7

Total Value£ 3.49 B

Avg. Deal Size£ 498 M

Market Context

Senior Management

Christiane Hamacher
CEO
Siddharth Mittal
CEO
Shreehas Tambe
CEO & Managing Director

Sort

07 Nov 2020|India|Pharmaceuticals

Target: BIOCON BIOLOGICS LTD

Bidder: GOLDMAN SACHS (MERCHANT BANKING DIVISION)

2 Service Providers

1 Target | 1 Bidder

6 Dealmakers

5 Target | 1 Bidder

£ 113 M

Value

07 Jan 2021|India|Pharmaceuticals

Target: BIOCON BIOLOGICS LTD

Bidder: ABU DHABI DEVELOPMENT CORPORATION (ADQ)

3 Service Providers

1 Target | 2 Bidder

3 Dealmakers

2 Target | 1 Bidder

£ 55 M

Value

17 Sep 2021|India|Pharmaceuticals

Target: BIOCON BIOLOGICS LTD

Bidder: SERUM INSTITUTE OF INDIA

3 Service Providers

2 Target | 1 Bidder

27 Dealmakers

27 Target | 1 Bidder

£ 541 M

Value

28 Feb 2022|United States|Biotechnology

Target: VIATRIS (BIOSIMILARS ASSETS)

Bidder: BIOCON BIOLOGICS LTD

15 Service Providers

8 Bidder | 7 Vendor

75 Dealmakers

36 Bidder | 39 Vendor

£ 2.49 B

Value

07 Sep 2022|India|Biotechnology

Target: SYNGENE

Bidder: VIATRIS

4 Service Providers

1 Target | 1 Bidder | 2 Vendor

8 Dealmakers

2 Target | 2 Bidder | 4 Vendor

£ 136 M

Value

08 Nov 2023|India|Medical Services

Target: BIOCON BIOLOGICS LTD (DERMATOLOGY AND NEPHROLOGY BRANDED FORMULATIONS BUSINESS UNITS)

Bidder: ERIS LIFESCIENCES

2 Service Providers

1 Bidder | 1 Vendor

2 Dealmakers

1 Bidder | 1 Vendor

£ 35 M

Value

14 Mar 2024|India|Biotechnology

Target: BIOCON BIOLOGICS (INDIAN BRANDED FORMULATIONS BUSINESS UNIT)

Bidder: ERIS LIFESCIENCES

3 Service Providers

1 Bidder | 2 Vendor

9 Dealmakers

3 Bidder | 6 Vendor

£ 117 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy